Learning 2 Sleep L2S (L2S.ST) Stock Analysis & AI Equity Report
Learning 2 Sleep L2S (L2S.ST) overview
Learning 2 Sleep L2S (L2S.ST) stock analysis and AI equity research. For the latest completed financial year, 2022, Learning 2 Sleep L2S reported revenue of SEK 3.4m and operating profit of SEK -18.3m; the year-end share price was 0.42 SEK and market capitalisation was SEK 5.1m. Learning 2 Sleep L2S is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Learning 2 Sleep L2S's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2025-09-03. Data will be refreshed during report generation.
About Learning 2 Sleep L2S
Learning 2 Sleep L2S AB provides digital healthcare services focused on sleep problems. The company offers an app-based sleep analysis and CBT-I treatment program, supported by coaching, recommendations, and audio exercises for individuals. It also works with employers, insurers, researchers, and healthcare partners through adapted sleep programs and data-based services.
Generate the Learning 2 Sleep L2S report
Learning 2 Sleep L2S is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Learning 2 Sleep L2S and represent the latest completed financial year (2022). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.